Office & Facilities Administrator

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

ESSENTIAL JOB FUNCTIONS:

Office and Reception Support

• Serve as the face of the company by greeting visitors and managing reception.
• Answer and route incoming calls/email; monitor voicemails.
• Coordinate conference room calendars and mediate scheduling conflicts.
• Manage mail, FedEx, and deliveries; drop off outgoing mail as needed.
• Manage and administer SpaceIQ seating and office reservation system

Administrative Support

• Prepare catering and logistical support for meetings, department lunches, and corporate events.
• Assist with onboarding by coordinating building access, office tours, and new hire setup.
• Submit and reconcile expense reports or corporate card charges.
• Support legal and HR teams with document handling, signatures, scheduling and coordination with notaries.

Facilities Coordination

• Maintain the office environment: stock supplies, maintain coffee machines, printers, and dishwashers, and oversee office cleanliness and organization.
• Coordinate with building management, vendors, and landlords regarding maintenance, repairs, and shared space reservations.
• Organize and support team-building events and celebrations.
• Support compound shipping by ensuring proper documentation is completed in advance.

Systems and Technology

• Partner with IT to assist with support tickets and general technical needs.
• Use Microsoft Outlook and Office 365 for scheduling and document management.
• Experience with SharePoint, Teams, and video conferencing tools preferred.

JOB SPECIFICATIONS:

• 2+ years of job experience providing administrative support
• Ability to speak effectively and communicate to visitors in a professional manner.
• Ability to work in a flexible, fast-changing environment and respond to needs quickly.
• Must be a team player who excels at customer service.
• Bachelor's degree preferred or combination of equivalent education, training or experience.
• Must be detail oriented and have demonstrated experience prioritizing and organizing multiple tasks simultaneously. Punctuality and a positive, cheerful attitude is a must.
• Experience with Office 365, SharePoint, Microsoft Teams preferred.
• Tech savvy and experience with Microsoft Outlook is a must—particularly being comfortable coordinating meetings and calendaring. Preferred experience with managing conference room calendars.

The hourly for this role is $30/hr. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.

#LI-RM1

Kura’s Values that are used for candidate selection and performance assessments:

• We work as one for patients
• We are goal-focused and deliver with excellence
• We are science-driven courageous innovators
• We strive to bring out the best in each other and ourselves

The Kura Package

• Career advancement/ development opportunities
• Competitive comp package
• Bonus
• 401K + Employer contributions
• Generous stock options
• ESPP Plan
• 20 days of PTO to start
• 18 Holidays  (Including Summer & Winter Break)
• Generous Benefits Package with a variety of plans available with a substantial employer match
• Paid Paternity/Maternity Leave
• In-Office Catered lunches
• Home Office Setup
• Lifestyle Spending Stipend
• Commuter Stipend (Boston Office)
• Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!

Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status. 

If you are a California resident, please see the attached Privacy Notice CA Privacy Notice